abstract |
This invention relates to methods and compositions for the treatment of cardiovascular disease, hypertriglyceridemia, low levels of lipoprotein lipase, low levels of HDL cholesterol and for increasing adipocyte differentiation using an RXR agonist in combination with a PPAR gamma agonist such as a thiazolidinedione compound. <IMAGE> |